The FDA has released a safety advisory warning practitioners not to co-prescribe linezolid with other serotonergic agents (including SSRIs, SNRIs, tricyclics, and others) to avoid the risk of serotonergic syndrome. The full list is available on the FDA site (FDA site)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.